Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/oncoscience.155 http://scihub22266oqcxt.onion/10.18632/oncoscience.155 C4468319!4468319 !26097867     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26097867 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Oncoscience 2015 ; 2 (4 ): 320-33 Nephropedia Template TP {{tp|p=26097867 |t=2015. AID/APOBEC deaminases and cancer |pdf=|usr=}}{{26097867 }} gab.com Text AID/APOBEC deaminases and cancer JO: Oncoscience http://www.kidney.de/pget.php?&tw=1&pmid=26097867 #FOAvip Mutations are the basis for evolution and the development of genetic diseases. Especially in cancer, somatic mutations in oncogenes and tumor suppressor genes alongside the occurrence of passenger mutations have been observed by recent deep-sequencing approaches. While mutations have long been considered random events induced by DNA-replication errors or by DNA damaging agents, genome sequencing led to the discovery of non-random mutation signatures in many human cancer. Common non-random mutations comprise DNA strand-biased mutation showers and mutations restricted to certain DNA motifs, which recently have become attributed to the activity of the AID/APOBEC family of DNA deaminases. Hence, APOBEC enzymes, which have evolved as key players in natural and adaptive immunity, have been proposed to contribute to cancer development and clonal evolution of cancer by inducing collateral genomic damage due to their DNA deaminating activity. This review focuses on how mutagenic events through AID/APOBEC deaminases may contribute to cancer development. Twit Text FOAVip AID/APOBEC deaminases and cancer ????Oncoscience http://www.kidney.de/pget.php?&tw=1&pmid=26097867 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26097867 #FOAvip English Wikipedia <ref>{{Cite pmid|26097867 }}</ref> AID/APOBEC deaminases and cancer #MMPMID26097867 Rebhandl S ; Huemer M ; Greil R ; Geisberger R Oncoscience 2015[]; 2 (4 ): 320-33 PMID26097867 show ga Mutations are the basis for evolution and the development of genetic diseases. Especially in cancer, somatic mutations in oncogenes and tumor suppressor genes alongside the occurrence of passenger mutations have been observed by recent deep-sequencing approaches. While mutations have long been considered random events induced by DNA-replication errors or by DNA damaging agents, genome sequencing led to the discovery of non-random mutation signatures in many human cancer. Common non-random mutations comprise DNA strand-biased mutation showers and mutations restricted to certain DNA motifs, which recently have become attributed to the activity of the AID/APOBEC family of DNA deaminases. Hence, APOBEC enzymes, which have evolved as key players in natural and adaptive immunity, have been proposed to contribute to cancer development and clonal evolution of cancer by inducing collateral genomic damage due to their DNA deaminating activity. This review focuses on how mutagenic events through AID/APOBEC deaminases may contribute to cancer development. äAID/APOBEC deaminases and cancer (epmc).pdf DeepDyve Pubget Overpricing